Literature DB >> 9040490

Regulation of paracrine cytokine balance controlling collagenase synthesis by corneal cells.

K J Strissel1, W B Rinehart, M E Fini.   

Abstract

PURPOSE: Classic studies have demonstrated that corneal epithelial cell density in culture can alter the balance of stimulatory and inhibitory cytokines controlling the elaboration of collagenolytic activity by co-cultured stromal cells. The current study attempts to bring the understanding of this mechanism to a molecular level.
METHODS: A rabbit primary corneal cell culture model was used.
RESULTS: Using molecular probes that bind to and neutralize specific cytokines, a major stimulator for stromal cell collagenase synthesis released by corneal epithelial cells into culture medium was identified as interleukin-1 alpha (IL-1 alpha), and a secondary stimulator was characterized as a heparin-binding cytokine. An inverse relationship between net collagenase stimulatory activity and epithelial cell plating density was demonstrated. In contrast, the release of inhibitory activity for IL-1-stimulated collagenase synthesis was not subject to the cell density effect. Direct measurement of IL-1 alpha protein levels revealed that this cytokine was released much more efficiently on a per cell basis when cells were plated at low density than when they were plated at high density. The effect was not caused by greater cell lysis at low cell density and was mediated only partially by changes at the IL-1 alpha synthesis level.
CONCLUSIONS: These data provide evidence that epithelial cells release stimulatory cytokines for collagenase expression more efficiently when they have limited contact with their neighbors and that this has important consequences for the overall paracrine cytokine balance controlling collagenase synthesis. Alteration of the paracrine cytokine balance by changes in cell contact may be an important means for regulating epithelial-stromal interactions involved in corneal development and repair.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040490

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Corneal wound healing after photorefractive keratectomy: a 3-year confocal microscopy study.

Authors:  Jay C Erie
Journal:  Trans Am Ophthalmol Soc       Date:  2003

2.  Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids.

Authors:  C F Singer; E Marbaix; I Kokorine; P Lemoine; J Donnez; Y Eeckhout; P J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.

Authors:  Gabriel M Gordon; Dolena R Ledee; William J Feuer; M Elizabeth Fini
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

4.  Analysis of the keratocyte apoptosis, keratocyte proliferation, and myofibroblast transformation responses after photorefractive keratectomy and laser in situ keratomileusis.

Authors:  Steven E Wilson
Journal:  Trans Am Ophthalmol Soc       Date:  2002

Review 5.  Prelude to corneal tissue engineering - gaining control of collagen organization.

Authors:  Jeffrey W Ruberti; James D Zieske
Journal:  Prog Retin Eye Res       Date:  2008-08-19       Impact factor: 21.198

6.  Clinical and immunological responses in ocular demodecosis.

Authors:  Jae Hoon Kim; Yeoun Sook Chun; Jae Chan Kim
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

7.  Potential underlying genetic associations between keratoconus and diabetes mellitus.

Authors:  Kristin M Ates; Amy J Estes; Yutao Liu
Journal:  Adv Ophthalmol Pract Res       Date:  2021-09-04

8.  Association of -31T>C and -511 C>T polymorphisms in the interleukin 1 beta (IL1B) promoter in Korean keratoconus patients.

Authors:  So-Hee Kim; Jee-Won Mok; Hyun-Seok Kim; C K Joo
Journal:  Mol Vis       Date:  2008-11-21       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.